NEW YORK (GenomeWeb) — Qiagen said Wednesday after the close of the market that its artus CMV RGQ MDx kit for human cytomegalovirus has been approved by the US Food and Drug Administration under a full premarket approval.

The test runs on Qiagen's Rotor-Gene Q MDx real-time PCR platform, which was cleared by the FDA in 2012 and is part of the QIAsymphony family of modular, automated instruments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.